CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 279 filers reported holding CYTOKINETICS INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,721 | -9.7% | 330 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $10,764 | -7.3% | 330 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $11,612 | -23.2% | 330 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $15,120 | +0.8% | 330 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $15,000 | +25.0% | 330 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $12,000 | 0.0% | 330 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $12,000 | -20.0% | 330 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $15,000 | +1400.0% | 330 | +230.0% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 100 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 100 | -42.9% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 175 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -66.7% | 175 | +20.7% | 0.00% | -100.0% |
| Q3 2017 | $3,000 | +50.0% | 145 | -17.1% | 0.00% | 0.0% |
| Q2 2017 | $2,000 | 0.0% | 175 | -32.7% | 0.00% | -50.0% |
| Q1 2014 | $2,000 | – | 260 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,989,218 | $47,348,000 | 10.09% |
| EcoR1 Capital, LLC | 2,139,697 | $20,306,000 | 8.01% |
| Healthcare Value Capital, LLC | 100,000 | $949,000 | 1.15% |
| DAFNA Capital Management LLC | 150,000 | $1,424,000 | 1.13% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 151,106 | $1,434,000 | 1.07% |
| Avoro Capital Advisors LLC | 503,900 | $4,782,000 | 1.06% |
| ACUTA CAPITAL PARTNERS, LLC | 140,969 | $1,338,000 | 0.64% |
| Iguana Healthcare Management, LLC | 150,000 | $1,424,000 | 0.58% |
| WASATCH ADVISORS LP | 1,746,096 | $16,570,000 | 0.25% |
| Virtus ETF Advisers LLC | 29,379 | $279,000 | 0.21% |